Compared with AAV-eGFP-treated ataxia mice, we observed a nearly 3-fold increase in mRNA expression of Gria1 in the DCN of AAV-Gria1-treated ataxia mice (Supplementary Fig. 10e). The gene discussed is GRIA1; the disease is cerebellar ataxia.